Name: Latest research reports of Cipla Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Cipla Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer

1502.4000 3.30 (0.22%)

NSE Jun 24, 2025 15:31 PM

Volume: 1.4M

Cipla Ltd.

14 Jun 2024

1502.40

0.22%

Cipla (HOLD): Valuations fully priced in; downgrade to HOLD

Hold: Cipla Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Strong traction in North America business and consistent performance in One-India; South Africa and Global Access business stabilising

Cipla Ltd. is trading below its 200 day SMA of 1507.8